Pubblicazioni

Advances in preventing adverse events during monoclonal antibody management of multiple sclerosis

2019 - EXPERT REVIEW OF NEUROTHERAPEUTICS
De Giglio, L.; Grimaldi, A. E.; Fubelli, F.; Marinelli, F.; Pozzilli, C.

Anti lingo 1 (opicinumab) a new monoclonal antibody tested in relapsing remitting multiple sclerosis

2017 - EXPERT REVIEW OF NEUROTHERAPEUTICS
Ruggieri, Serena; Tortorella, Carla; Gasperini, Claudio

Natalizumab in multiple sclerosis: Discontinuation, progressive multifocal leukoencephalopathy and possible use in children

2015 - EXPERT REVIEW OF NEUROTHERAPEUTICS
Vitaliti, Giovanna; Matin, Nassim; Tabatabaie, Omidreza; DI TRAGLIA, Mario; Pavone, Piero; Lubrano, Riccardo; Falsaperla, Raffaele

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma